| |
|
|
|
Altimmune Inc  
|
|
14.35 0.78 (0.06%) |
09-22 16:00 |
|
Open: |
13.52 |
Pre close: |
13.57 |
Target:
|
24.43 
|
|
High: |
14.52 |
Low: |
13.1445 |
Resistance:
|
20.92
26.58
|
|
Volume: |
1,399,135 |
Market Cap: |
472M |
Support:
|
11.75
9.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
13.98
 |
MACD |
MACD(12,26):
|
-2.04 |
|
MA(20): |
14.65 |
Signal(12,26,9): |
-2.36 |
|
MA(100): |
14.83 |
Stochastic Oscillator |
%K(14,3):
|
38.44 |
|
MA(250): |
7.26 |
%D(3): |
33.61 |
|
Average Volume(K) |
3-Month: |
405232
|
52-Week |
High:
|
35.10 |
|
10-Days: |
178828 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
41.59 |
Change(%): |
613.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.270 |
Return on Equity (ttm) |
-52.6 |
Shares Out. (M) |
32.91 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-20.2 |
Shares Float (M) |
23.89 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.11 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-55.6 |
% Held by Institutions |
8.38 |
|
Forward EPS |
-1.600 |
Gross Profit (p.s.) |
-0.343 |
Shares Short (K) |
1020 |
|
Book Value (p.s.) |
3.030 |
EBITDA (p.s.) |
-0.799 |
P/E |
-6.32 |
|
Sales Per Share |
0.126 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.95 |
P/S |
113.80 |
|
Operating Margin |
-640.09 |
Levered Free Cash Flow
(M) |
-17.71 |
P/CF |
-29.61 |
|
|
|
|
|
|
